Modalis Therapeutics (4883.TSE) Q2 2024 Earnings

8MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-14.5
-13.02
-11.55
-10.07

Details

Expected EPS
N/A
Actual EPS
-13.947131021390001
Surprise EPS
-13.95
Surprise Percent
+∞%

Description

Modalis Therapeutics (4883.TSE) has reported earnings of -13.947131021390001 per share for Q2 2024.

0 Comments

Share your thoughts